Expertise in
17
conditions

Dr. Carlos A. Sesin

Rheumatology
Office
1801 Ponce De Leon Blvd, 
Coral Gables, FL 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
17
conditions
Office
1801 Ponce De Leon Blvd, 
Coral Gables, FL 

Overview

Carlos Sesin is a Rheumatologist practicing medicine in Coral Gables, Florida.

Dr. Sesin is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Rheumatoid Arthritis (RA), and Psoriatic Arthritis.

He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 4 clinical trials. Dr. Sesin is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in FL

Hospital Affiliations

South Miami Hospital
Memorial Regional Hospital
Mount Sinai Medical Center Of Florida, Inc
Doctors Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 24 Less Insurance Carriers -

Locations

Office
1801 Ponce De Leon Blvd, Coral Gables, FL 33134

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Biological, Drug
Study Drugs: GSK3196165, Tofacitinib, Methotrexate, Folic acid
Study Phase: Phase 3
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Otilimab, csDMARD
Study Phase: Phase 3
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Combination product
Study Drugs: Abaloparatide solid microstructured transdermal system, Abaloparatide subcutaneous
Study Phase: Phase 3
View 3 Less Clinical Trials

4 Total Publications

Concomitant Use of Steroids and Immunotherapy in a Patient With Paraneoplastic Dermatomyositis and Gastroesophageal Adenocarcinoma.
Concomitant Use of Steroids and Immunotherapy in a Patient With Paraneoplastic Dermatomyositis and Gastroesophageal Adenocarcinoma.
Journal: Cureus
Published: October 25, 2023
Similar Doctors
Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required
Before you request

Umhc-Sylvester Comprehensive Cancer Center

1475 NW 12th Ave, 
Miami, FL 
 (3.6 miles away)
305-243-7545
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dana Ascherman is a Rheumatologist practicing medicine in Miami, Florida. Dr. Ascherman is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Myositis, Rheumatoid Lung Disease, Dermatomyositis, and Polymyositis.

Expertise in
17
conditions
Dr. Olga Kromo
Rheumatology
Expertise in
17
conditions
Dr. Olga Kromo
Rheumatology
Referral required
Before you request

American Arthritis & Rheumatology Associates LLC

6280 Sunset Dr Ste 501, 
South Miami, FL 
 (4.3 miles away)
305-671-3447
Languages Spoken:
English, Russian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Olga Kromo is a Rheumatologist practicing medicine in South Miami, Florida. Dr. Kromo is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Psoriatic Arthritis, Rheumatoid Vasculitis, Psoriasis, and Ankylosing Spondylitis. Dr. Kromo is board certified in American Board Of Internal Medicine. Dr. Kromo is currently accepting new patients.

Expertise in
39
conditions
Dr. John P. Donohue
Rheumatology
Expertise in
39
conditions
Dr. John P. Donohue
Rheumatology
Referral may be required

Egil And Pauline Braathen Center/Maroone Cancer Center

2950 Cleveland Clinic Boulevard, 
Weston, FL 
 (23.4 miles away)
877-463-2010
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Donohue is a Rheumatologist practicing medicine in Weston, Florida. Dr. Donohue is highly rated in 39 conditions, according to our data. His clinical expertise encompasses MASS Phenotype, Mixed Connective Tissue Disease, Necrotizing Vasculitis, and Temporal Arteritis. Dr. Donohue is board certified in American Board Of Internal Medicine, 1997.

Frequently Asked Questions about Dr. Carlos A. Sesin

How do I make an appointment with Dr. Carlos A. Sesin?

You can book an appointment with Dr. Carlos A. Sesin by calling their office at 305-531-6766. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Carlos A. Sesin a top-rated expert for Postmenopausal Osteoporosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Carlos A. Sesin is classified as an Distinguished expert for Postmenopausal Osteoporosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Carlos A. Sesin specialize in?

While Dr. Carlos A. Sesin is a Rheumatology, they have specific expertise in Postmenopausal Osteoporosis, Osteoporosis, and Rheumatoid Arthritis (RA). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Carlos A. Sesin participate in research or clinical trials?

Yes. Dr. Carlos A. Sesin has published 4 articles and abstracts on conditions like Postmenopausal Osteoporosis. You can view a list of Dr. Carlos A. Sesin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Carlos A. Sesin accept my insurance?

Dr. Carlos A. Sesin accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 305-531-6766 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sesin's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 25 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile